{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/06/02/3305741/0/en/Zenas-BioPharma-Announces-Data-from-the-Registrational-Phase-3-INDIGO-Trial-of-Obexelimab-in-Immunoglobulin-G4-Related-Disease-IgG4-RD-Simultaneously-Presented-at-the-EULAR-2026-Co.html", "message": "News view counter 776423 successfully enlarged"}